Media ReleasesStirling Products Limited

View All Stirling Products Limited News


6 May 2011

- Ex Novartis and Pfizer Executive to be appointed as CEO

- Ex IBM Director appointed as Advisor and Consultant

Healthcare group, Stirling Products Limited (ASX:STI) is pleased to advise of the appointment of Mr Jeremy Cocks as its Chief Executive Officer – designate following a long executive search. Jeremy has extensive expertise in the pharmaceutical animal health sector and has proven sales, marketing and management experience in Australia, the US and the UK. He was recently the Head of Marketing and Technical Services at Novartis and previously a Director of Pfizer where in the USA he headed up New Products Marketing and Business Development. The appointment is to be formalised by 6 June 2011 and is subject to a probationary term of three months and Board approval. The Company will advise conditions of employment following Board Approval and formal appointment.

The company further advises the appointment of UK based Mr. John Botten as an advisor and consultant to the Company. John has extensive multi-national experience including 31 years at IBM where he was a director for 12 years, including four years at IBM’s European HQ in France as the Product Director responsible for the marketing of IBM’s large systems across EMEA and four years as the Commercial Director on the main IBM UK Board.

For further information please download PDF below:

Download this document